Our news

PHARCO Pharmaceuticals, Inc. receives World Health Organization Prequalification for HCV Medicine Sofosbuvir Tablets

Alexandria, Egypt – February 15, 2019

PHARCO Pharmaceuticals, Inc. announced today that the World Health Organization (WHO) has awarded prequalification for SOFOSBUVIR 400 mg Tablets manufactured at its European Egyptian Pharmaceutical Industries (EEPI) Factory for the treatment of Hepatitis C Virus (HCV).

Read more


22 Sept 2017

Dr. Seif Helmy, head of “Enqez Hayatak” campaign, said that the campaign team was keen to raise awareness at the highest level to implement the national project sponsored by the President Abdelfatah Al Sisi, "Egypt free of Hepatitis C 2020 ".
Read more


23 July 2017

Dr. Sherine Helmi announced the start of intensive research with American universities and Egyptian researchers to find an affordable Egyptian medicine to treat cancer during three years, which will be 100% Egyptian.

Read more


23 May 2017

Pharco's Portuguese Coach"Roy Aguache" said that his goal is to move forward with the team to the Premier League after he officially became the team coach.

view more


10 May 2017

More than 800,000 Egyptians have been cured from hepatitis C since January 2016 and 2020 will not see this country with one single Virus C patient

Read more


3 Oct 2016

The President of Egypt announced last week that Egypt today has no waiting list for patients requesting treatment and the focus is now on prevention and case detection

Read more